DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Bigal ME, Escandon R, Bronson M et al.
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program.
Cephalalgia 2013;
34: 483-492
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.